Delivery Order SPE2DB20D1004-SPE2DB21FF4R3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care materials,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $6,337.12, is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, syringes, vials, and other critical care materials, to support military treatment...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, provides the DLA with a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued up to $999,999,999.00. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities,...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF4R3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The award, which does not have a set-aside designation, demonstrates Amerisourcebergen's position as a critical supplier of essential medical commodities to the Department of Defense and other federal agencies. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/15/21 |